Delving in folate metabolism in the parasite Leishmania major through a chemogenomic screen and methotrexate selection
PLOS Neglected Tropical Diseases · 2023
DOI: 10.1371/journal.pntd.0011458 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Sophia Bigot und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche en Infectiologie du Centre de Recherche du CHU de Québec and Département de Microbiologie, Infectiologie et Immunologie, Faculté …. Hauptthemen laut MEDLINE: Leishmania major, Folic Acid Antagonists, Parasites. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Institute of Infection and Immunity.
Abstract (Originalsprache)
Most of our understanding of folate metabolism in the parasite Leishmania is derived from studies of resistance to the antifolate methotrexate (MTX). A chemical mutagenesis screen of L . major Friedlin and selection for resistance to MTX led to twenty mutants with a 2- to 400-fold decrease in MTX susceptibility in comparison to wild-type cells. The genome sequence of the twenty mutants highlighted recurrent mutations (SNPs, gene deletion) in genes known to be involved in folate metabolism but also in novel genes. The most frequent events occurred at the level of the locus coding for the folate transporter FT1 and included gene deletion and gene conversion events, as well as single nucleotide changes. The role of some of these FT1 point mutations in MTX resistance was validated by gene editing. The gene DHFR-TS coding for the dihydrofolate reductase-thymidylate synthase was the second locus with the most mutations and gene editing confirmed a role in resistance for some of these. The pteridine reductase gene PTR1 was mutated in two mutants. The episomal overexpression of the mutated versions of this gene, but also of DHFR-TS , led to parasites several fold more resistant to MTX than those overexpressing the wild-type versions. Genes with no known link with folate metabolism and coding for a L-galactolactone oxidase or for a methyltransferase were mutated in specific mutants. Overexpression of the wild-type versions of these genes in the appropriate mutants reverted their resistance. Our Mut-seq approach provided a holistic view and a long list of candidate genes potentially involved in folate and antifolate metabolism in Leishmania .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre de Recherche en Infectiologie du Centre de Recherche du CHU de Québec and Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Quebec City, Québec, Canada.
ORCID-Profile: Marc Ouellette
Förderung
- CIHR
- Institute of Infection and Immunity
Zitieren
APA
Bigot, S., Leprohon, P., & Ouellette, M. (2023). Delving in folate metabolism in the parasite Leishmania major through a chemogenomic screen and methotrexate selection. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011458
Vancouver
Bigot S, Leprohon P, Ouellette M. Delving in folate metabolism in the parasite Leishmania major through a chemogenomic screen and methotrexate selection. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011458
BibTeX
@article{Bigot2023,
author = {Bigot, Sophia and Leprohon, Philippe and Ouellette, Marc},
title = {Delving in folate metabolism in the parasite Leishmania major through a chemogenomic screen and methotrexate selection},
journal = {PLOS Neglected Tropical Diseases},
year = {2023},
doi = {10.1371/journal.pntd.0011458}
}
EUVIMED